Nicholas Rebold

423 total citations · 1 hit paper
12 papers, 256 citations indexed

About

Nicholas Rebold is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Nicholas Rebold has authored 12 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Molecular Medicine. Recurrent topics in Nicholas Rebold's work include Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antibiotic Use and Resistance (4 papers). Nicholas Rebold is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antibiotic Use and Resistance (4 papers). Nicholas Rebold collaborates with scholars based in United States, Thailand and Saudi Arabia. Nicholas Rebold's co-authors include Dana Holger, Amer El Ghali, Ashlan J. Kunz Coyne, Michael J. Rybak, Michael J. Rybak, Sara Alosaimy, Taylor Morrisette, Michael P. Veve, Abdalhamid M Lagnf and William J Moore and has published in prestigious journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Microbiology Spectrum and Open Forum Infectious Diseases.

In The Last Decade

Nicholas Rebold

12 papers receiving 252 citations

Hit Papers

Therapeutic Strategies for Emerging Multidrug-Resistant P... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
    2022 162 citations Ashlan J. Kunz Coyne, Amer El Ghali et al. Infectious Diseases and Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Rebold United States 7 149 83 72 67 44 12 256
Jonathan C. Cho United States 10 141 0.9× 87 1.0× 126 1.8× 53 0.8× 72 1.6× 18 332
Ali F. Aboklaish United Kingdom 8 170 1.1× 41 0.5× 75 1.0× 52 0.8× 77 1.8× 13 282
Jinju Duan China 9 122 0.8× 40 0.5× 35 0.5× 78 1.2× 40 0.9× 31 285
Ngai Kien Le Vietnam 8 164 1.1× 76 0.9× 56 0.8× 34 0.5× 63 1.4× 10 253
Maxime Bour France 12 262 1.8× 55 0.7× 76 1.1× 79 1.2× 41 0.9× 19 314
Federica Maria Di Lella Italy 9 142 1.0× 56 0.7× 69 1.0× 62 0.9× 56 1.3× 14 285
Ngoc Thi Bich Hoang Vietnam 8 162 1.1× 58 0.7× 49 0.7× 35 0.5× 51 1.2× 13 233
Amer El Ghali United States 9 171 1.1× 71 0.9× 69 1.0× 111 1.7× 44 1.0× 14 326
Liliane Okdah Saudi Arabia 9 247 1.7× 42 0.5× 63 0.9× 69 1.0× 45 1.0× 24 294
Hariharan Periasamy India 12 235 1.6× 88 1.1× 156 2.2× 60 0.9× 72 1.6× 19 332

Countries citing papers authored by Nicholas Rebold

Since Specialization
Citations

This map shows the geographic impact of Nicholas Rebold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Rebold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Rebold more than expected).

Fields of papers citing papers by Nicholas Rebold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Rebold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Rebold. The network helps show where Nicholas Rebold may publish in the future.

Co-authorship network of co-authors of Nicholas Rebold

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Rebold. A scholar is included among the top collaborators of Nicholas Rebold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Rebold. Nicholas Rebold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Holger, Dana, et al.. (2024). Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 44(3). 268–282. 3 indexed citations
3.
Coyne, Ashlan J. Kunz, Amer El Ghali, Nicholas Rebold, et al.. (2023). High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open Forum Infectious Diseases. 10(3). ofad034–ofad034. 15 indexed citations
4.
Rebold, Nicholas, Abdalhamid M Lagnf, Sara Alosaimy, et al.. (2023). Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology Spectrum. 11(1). e0264722–e0264722. 14 indexed citations
5.
Rebold, Nicholas, et al.. (2023). Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(3). 247–256. 3 indexed citations
6.
7.
Rebold, Nicholas, Sara Alosaimy, Taylor Morrisette, et al.. (2022). Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19. Infectious Diseases and Therapy. 11(3). 1281–1296. 5 indexed citations
8.
Coyne, Ashlan J. Kunz, Amer El Ghali, Dana Holger, Nicholas Rebold, & Michael J. Rybak. (2022). Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infectious Diseases and Therapy. 11(2). 661–682. 162 indexed citations breakdown →
9.
Ghali, Amer El, Taylor Morrisette, Kyle C. Molina, et al.. (2022). 1422. A Multi-Center Evaluation of Omadacycline for Multi-Drug Resistant Infections. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations
10.
Rebold, Nicholas, Taylor Morrisette, Abdalhamid M Lagnf, et al.. (2021). Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. Open Forum Infectious Diseases. 8(12). ofab554–ofab554. 24 indexed citations
11.
Rebold, Nicholas, Dana Holger, Sara Alosaimy, Taylor Morrisette, & Michael J. Rybak. (2021). COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options. Infectious Diseases and Therapy. 10(1). 93–113. 9 indexed citations
12.
Alosaimy, Sara, Abdalhamid M Lagnf, Taylor Morrisette, et al.. (2021). Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant Staphylococcus aureus Bacteremia: STAPH Study. Open Forum Infectious Diseases. 8(7). ofab261–ofab261. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan C. Cho Breakdown of academic impact, for papers by Ali F. Aboklaish Breakdown of academic impact, for papers by Jinju Duan Breakdown of academic impact, for papers by Ngai Kien Le Breakdown of academic impact, for papers by Maxime Bour Breakdown of academic impact, for papers by Federica Maria Di Lella Breakdown of academic impact, for papers by Ngoc Thi Bich Hoang Breakdown of academic impact, for papers by Amer El Ghali Breakdown of academic impact, for papers by Liliane Okdah Breakdown of academic impact, for papers by Hariharan Periasamy
Rankless by CCL
2026